This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Yasuhito Onodera: Innovator in Oncogenic Signaling Research
Introduction
Yasuhito Onodera is a prominent inventor based in Sapporo, Japan. He has made significant contributions to the field of cancer research, particularly in understanding the metabolic pathways associated with oncogenesis. His innovative work has led to the development of methods that correlate glucose metabolism with cancer signaling.
Latest Patents
Yasuhito Onodera holds a patent titled "Use of glycolytic pathways for inhibiting or measuring oncogenic signaling." This patent discloses methods in which glucose metabolism is correlated to oncogenesis through specific pathways. The invention demonstrates that the inhibition of certain enzymes can interfere with oncogenic signaling. Furthermore, it highlights the measurement of enzyme levels as a correlation with patient survival. The methods involve measuring the expression levels of enzymes involved in glucose uptake or metabolism, where increased expression relative to normal cells correlates with poor disease prognosis. The genes measured include GLUT3, PFKP, GAPDH, ALDOC, LDHA, and GFPT2. Additionally, the patent discusses downregulating the expression of certain genes in glucose uptake and metabolism.
Career Highlights
Yasuhito Onodera is affiliated with the University of California, where he conducts his research. His work has garnered attention for its potential implications in cancer treatment and patient outcomes. He has dedicated his career to exploring the intricate relationship between metabolism and cancer, contributing valuable insights to the scientific community.
Collaborations
Yasuhito Onodera collaborates with Mina J Bissell, a notable figure in cancer research. Their partnership exemplifies the importance of interdisciplinary collaboration in advancing scientific knowledge and innovation.
Conclusion
Yasuhito Onodera's contributions to the field of oncogenic signaling through his innovative patent highlight the critical intersection of metabolism and cancer research. His work continues to pave the way for future advancements in understanding and treating cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile